Home NDC 69238-1158-3 Ezetimibe and Simvastatin
Product NDC 69238-1158
Requested package NDC 69238-1158-3
11-digit product format 692381158
Labeler code 69238
Product ID 69238-1158_73b04380-a0cd-4177-a5fc-4f0f8b675f2a
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Ezetimibe and Simvastatin
Dosage form TABLET
Route ORAL
Labeler Amneal Pharmaceuticals NY LLC
Application ANDA208831
Marketing category ANDA
Marketing start 2017-11-21
Marketing end 0000-00-00
Substance EZETIMIBE; SIMVASTATIN
Active strength 10 mg/1; mg/1
Pharmacologic classes Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
NDC exclude flag No
Listing certified through 2023-12-31
Current FDA listing Historical FDA.report record
Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 4 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A208831-001 EZETIMIBE AND SIMVASTATIN EZETIMIBE; SIMVASTATIN 10MG;10MG TABLET / ORAL 2017-11-21 A208831-002 EZETIMIBE AND SIMVASTATIN EZETIMIBE; SIMVASTATIN 10MG;20MG TABLET / ORAL 2017-11-21 A208831-003 EZETIMIBE AND SIMVASTATIN EZETIMIBE; SIMVASTATIN 10MG;40MG TABLET / ORAL 2017-11-21 A208831-004 EZETIMIBE AND SIMVASTATIN EZETIMIBE; SIMVASTATIN 10MG;80MG TABLET / ORAL 2017-11-21
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 5 · 172 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 A208831-001 EZETIMIBE AND SIMVASTATIN 10MG;10MG TABLET / ORAL 2017-11-21 84e616aacf4f…2026-09-14 22:38:34 2026-08 A208831-002 EZETIMIBE AND SIMVASTATIN 10MG;20MG TABLET / ORAL 2017-11-21 84e616aacf4f…2026-09-14 22:38:34 2026-08 A208831-003 EZETIMIBE AND SIMVASTATIN 10MG;40MG TABLET / ORAL 2017-11-21 84e616aacf4f…2026-09-14 22:38:34 2026-08 A208831-004 EZETIMIBE AND SIMVASTATIN 10MG;80MG TABLET / ORAL 2017-11-21 84e616aacf4f…2026-08-18 06:07:40 2026-07 A208831-001 EZETIMIBE AND SIMVASTATIN 10MG;10MG TABLET / ORAL 2017-11-21 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A208831-002 EZETIMIBE AND SIMVASTATIN 10MG;20MG TABLET / ORAL 2017-11-21 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A208831-003 EZETIMIBE AND SIMVASTATIN 10MG;40MG TABLET / ORAL 2017-11-21 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A208831-004 EZETIMIBE AND SIMVASTATIN 10MG;80MG TABLET / ORAL 2017-11-21 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A208831-001 EZETIMIBE AND SIMVASTATIN 10MG;10MG TABLET / ORAL 2017-11-21 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A208831-002 EZETIMIBE AND SIMVASTATIN 10MG;20MG TABLET / ORAL 2017-11-21 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A208831-003 EZETIMIBE AND SIMVASTATIN 10MG;40MG TABLET / ORAL 2017-11-21 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A208831-004 EZETIMIBE AND SIMVASTATIN 10MG;80MG TABLET / ORAL 2017-11-21 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A208831-001 EZETIMIBE AND SIMVASTATIN 10MG;10MG TABLET / ORAL 2017-11-21 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A208831-002 EZETIMIBE AND SIMVASTATIN 10MG;20MG TABLET / ORAL 2017-11-21 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A208831-003 EZETIMIBE AND SIMVASTATIN 10MG;40MG TABLET / ORAL 2017-11-21 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A208831-004 EZETIMIBE AND SIMVASTATIN 10MG;80MG TABLET / ORAL 2017-11-21 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A208831-001 EZETIMIBE AND SIMVASTATIN 10MG;10MG TABLET / ORAL 2017-11-21 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A208831-002 EZETIMIBE AND SIMVASTATIN 10MG;20MG TABLET / ORAL 2017-11-21 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A208831-003 EZETIMIBE AND SIMVASTATIN 10MG;40MG TABLET / ORAL 2017-11-21 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A208831-004 EZETIMIBE AND SIMVASTATIN 10MG;80MG TABLET / ORAL 2017-11-21 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A208831-001 EZETIMIBE AND SIMVASTATIN 10MG;10MG TABLET / ORAL AB 2017-11-21 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A208831-002 EZETIMIBE AND SIMVASTATIN 10MG;20MG TABLET / ORAL AB 2017-11-21 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A208831-003 EZETIMIBE AND SIMVASTATIN 10MG;40MG TABLET / ORAL AB 2017-11-21 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A208831-004 EZETIMIBE AND SIMVASTATIN 10MG;80MG TABLET / ORAL AB 2017-11-21 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A208831-001 EZETIMIBE AND SIMVASTATIN 10MG;10MG TABLET / ORAL AB 2017-11-21 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A208831-002 EZETIMIBE AND SIMVASTATIN 10MG;20MG TABLET / ORAL AB 2017-11-21 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A208831-003 EZETIMIBE AND SIMVASTATIN 10MG;40MG TABLET / ORAL AB 2017-11-21 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A208831-004 EZETIMIBE AND SIMVASTATIN 10MG;80MG TABLET / ORAL AB 2017-11-21 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A208831-001 EZETIMIBE AND SIMVASTATIN 10MG;10MG TABLET / ORAL AB 2017-11-21 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A208831-002 EZETIMIBE AND SIMVASTATIN 10MG;20MG TABLET / ORAL AB 2017-11-21 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A208831-003 EZETIMIBE AND SIMVASTATIN 10MG;40MG TABLET / ORAL AB 2017-11-21 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A208831-004 EZETIMIBE AND SIMVASTATIN 10MG;80MG TABLET / ORAL AB 2017-11-21 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A208831-001 EZETIMIBE AND SIMVASTATIN 10MG;10MG TABLET / ORAL AB 2017-11-21 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A208831-002 EZETIMIBE AND SIMVASTATIN 10MG;20MG TABLET / ORAL AB 2017-11-21 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A208831-003 EZETIMIBE AND SIMVASTATIN 10MG;40MG TABLET / ORAL AB 2017-11-21 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A208831-004 EZETIMIBE AND SIMVASTATIN 10MG;80MG TABLET / ORAL AB 2017-11-21 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A208831-001 EZETIMIBE AND SIMVASTATIN 10MG;10MG TABLET / ORAL AB 2017-11-21 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A208831-002 EZETIMIBE AND SIMVASTATIN 10MG;20MG TABLET / ORAL AB 2017-11-21 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A208831-003 EZETIMIBE AND SIMVASTATIN 10MG;40MG TABLET / ORAL AB 2017-11-21 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A208831-004 EZETIMIBE AND SIMVASTATIN 10MG;80MG TABLET / ORAL AB 2017-11-21 5bbf6a4d5a75…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 4 · 148 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 69238-1158-3 Ezetimibe and Simvastatin 30 in 1 BOTTLE TABLET 30 13 69238-1158-9 Ezetimibe and Simvastatin 90 in 1 BOTTLE TABLET 90 13
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 69238-1158 EZETIMIBE AND SIMVASTATIN TABLET [AMNEAL PHARMACEUTICALS NY LLC] 13 Legacy NDC, 2 package rows 20250427_5ea3ca31-cfee-4978-8b7a-755986f6b091.zip
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 69238-1158-3 69238115803 30 TABLET in 1 BOTTLE (69238-1158-3) 30 tablet 2017-11-21 0000-00-00 No No Current